Rallybio Corporaton (RLYB)
0.6700 x 16 0.6955 x 5
Post-market by (Cboe BZX)
0.6700 -0.0300 (-4.29%) 03/21/25 [NASDAQ]
0.6700 x 16 0.6955 x 5
Post-market 0.6700 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,903 | 24,494 | 56,958 | 175,334 | 140,233 |
| Marketable Securities | 51,608 | 85,435 | 112,036 | N/A | N/A |
| TOTAL | $67,841 | $114,789 | $179,496 | $180,869 | $141,261 |
| Non-Current Assets | |||||
| PPE Net | 115 | 246 | 385 | 511 | 287 |
| Investments And Advances | 0 | 239 | 30 | 805 | 310 |
| Other Non-Current Assets | 152 | 346 | 524 | 0 | 0 |
| TOTAL | $267 | $831 | $939 | $1,316 | $597 |
| Total Assets | $68,108 | $115,620 | $180,435 | $182,185 | $141,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 278 | 976 | 1,114 | 603 | 1,579 |
| Accrued Expenses | 4,962 | 8,068 | 9,449 | 5,948 | 4,264 |
| TOTAL | $6,242 | $9,263 | $10,744 | $6,551 | $5,843 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 848 | N/A | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 0 | 173 | 374 | 32 | 12 |
| TOTAL | $212 | $173 | $374 | $32 | $12 |
| Total Liabilities | $6,454 | $9,436 | $11,118 | $6,583 | $5,855 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,612 | 37,812 | 38,075 | 32,131 | N/A |
| Common Shares | 4 | 4 | 4 | 3 | 2 |
| Retained earnings | -293,020 | -235,245 | -160,681 | -94,027 | -47,014 |
| Other shareholders' equity | 68 | 15 | -214 | 0 | 0 |
| TOTAL | $61,654 | $106,184 | $169,317 | $175,602 | $136,003 |
| Total Liabilities And Equity | $68,108 | $115,620 | $180,435 | $182,185 | $141,858 |